FDA expands indication of dust mite allergy drug to include young children
The U.S. Food and Drug Administration has expanded its indication of ALK's Odactra, a house dust mite allergen tablet, for the treatment of house dust mite-induced allergic rhinitis, with or without conjunctivitis, to include ...
Mar 6, 2025
0
0